A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Infection and Immunity

• Publication date

  1985-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/iai.48.3.747-753.1985PMID 2860069PMCID PMC261250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.

  1984cited by this paper
• Bacterial toxins: cellular mechanisms of action

  1984cited by this paper
• Guinea pig macroalbumin. A major inhibitor of activated Hageman factor in plasma with an alpha 2-macroglobulin-like nature.

  1984cited by this paper
• Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease.

  1984cited by this paper
• Purification and characterization of four proteases from a clinical isolate of Serratia marcescens kums 3958

  1984influential reference
• Importance of serratia protease in the pathogenesis of experimental Serratia marcescens pneumonia

  1983cited by this paper
• Guinea pig macroalbumin : a major inhibitor of activated hageman factor in plasma with α2-macroglobulin-like nature

  1983cited by this paper
• Serratia keratitis transmitted by contaminated eyedroppers.

  1982cited by this paper
• A protease-like permeability factor in guinea pig skin: immunologic identity with plasma Hageman factor.

  1982cited by this paper
• Guinea pig Hageman factor as a vascular permeability enhancement factor.

  1981cited by this paper
• Characterization of rabbit corneal damage produced by Serratia keratitis and by a serratia protease

  1981cited by this paper
• Visual outcome in eight cases of Serratia marcescens keratitis.

  1981cited by this paper
• Hageman factor fragment inhibitor in corn seeds: purification and characterization.

  1980cited by this paper
• Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.

  1980cited by this paper
• Adenosine diphosphate-ribosylation of adenylate cyclase catalyzed by heat-labile enterotoxin of Escherichia coli: comparison with cholera toxin.

  1980influential reference
• Purification and Characterization of a Serratia marcescens Metalloprotease

  1979cited by this paper
• Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli

  1978cited by this paper
• Intraocular gentamicin as intraoperative prophylaxis in South India eye camps.

  1977cited by this paper
• Infective keratitis in soft contact lens wearers.

  1977cited by this paper
• Effects in the Rat of Intradermal Injection of Purified Proteinases from Streptococcus and Serratia Marcescens 1

  1975influential reference
• Simple Method for Quantitation of Enhanced Vascular Permeability 1

  1970cited by this paper
• Serratia marcescens keratoconjunctivitis.

  1970cited by this paper
• Serratia marcescens. A pathogen of increasing clinical importance.

  1970influential reference
• [A case of serpiginous corneal ulcer caused by Serratia of Enterobacteriaceae].

  1969cited by this paper

• Bacterial zinc metalloproteases as facilitators of pathogenic success: a review

  2026cites this paper
• Ultrasound-mediated nanomaterials for the treatment of inflammatory diseases

  2025cites this paper
• Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms.

  2022cites this paper
• Transcription Factor EepR Is Required for Serratia marcescens Host Proinflammatory Response by Corneal Epithelial Cells

  2021cites this paper
• Factors affecting the dynamics and heterogeneity of the EPR effect: pathophysiological and pathoanatomic features, drug formulations and physicochemical factors

  2021cites this paper
• Responsive Polymeric Nanoparticles for Biofilm-infection Control

  2021cites this paper
• The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects

  2021cites this paper
• Polymeric micelle-based drug delivery systems for tuberculosis treatment

  2020cites this paper
• Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers.

  2020cites this paper
• Controlled drug delivery systems in eradicating bacterial biofilm-associated infections.

  2020cites this paper
• α-Amino acid N-carboxyanhydride (NCA)-derived synthetic polypeptides for nucleic acids delivery.

  2020cites this paper
• CpxR-Dependent Thermoregulation of Serratia marcescens PrtA Metalloprotease Expression and Its Contribution to Bacterial Biofilm Formation

  2018cites this paper
• Correction to: Pluronic‑based nano‑self‑assemblies of bacitracin A with a new mechanism of action for an efficient in vivo therapeutic effect against bacterial peritonitis

  2018cites this paper
• Pluronic-based nano-self-assemblies of bacitracin A with a new mechanism of action for an efficient in vivo therapeutic effect against bacterial peritonitis

  2018cites this paper
• Biodegradable and Biocompatible Polymers‐Based Drug Delivery Systems for Cancer Therapy

  2015cites this paper
• Proteomics in the Study of Bacterial Keratitis

  2015cites this paper
• Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect

  2014cites this paper
• Molecular Characterization of Protease Activity in Serratia sp. Strain SCBI and Its Importance in Cytotoxicity and Virulence

  2014cites this paper
• The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.

  2013cites this paper
• marcescens.56-kilodalton proteinase from Serratia and the complement system in human plasma Inactivation of various proteinase inhibitors

  2013cites this paper
• The enhanced permeability retention effect: a new paradigm for drug targeting in infection.

  2013cites this paper
• Friend or foe? A review of the mechanisms that drive Serratia towards diverse lifestyles.

  2013cites this paper
• The link between infection and cancer: Tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect

  2013cites this paper
• Nanoparticle targeting to inflamed tissues of the gastrointestinal tract.

  2013cites this paper
• Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting

  2012cites this paper
• PEGylated d-amino acid oxidase restores bactericidal activity of neutrophils in chronic granulomatous disease via hypochlorite

  2012cites this paper
• 19 Kinins in bacterial infections

  2011cites this paper
• Effect of meropenem on the vascular permeability factor produced by Acinetobacter baumannii.

  2011cites this paper
• The role of Serratia marcescens in soft contact lens associated ocular infections. A review.

  2009cites this paper
• Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

  2009cites this paper
• Coral disease pathogens of the Indo-Pacific Ocean

  2009cites this paper
• Coral Pathogens Identified for White Syndrome (WS) Epizootics in the Indo-Pacific

  2008cites this paper
• Proteolytic activity inSerratia marcescens clinical isolates

  2008cites this paper
• Inhibitory effects of ovomacroglobulin on bacterial keratitis in rabbits

  2004cites this paper
• Role of bacterial proteases in pseudomonal and serratial keratitis

  2004cites this paper
• Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.

  2003cites this paper
• Macromolecular Therapeutics

  2003cites this paper
• Enhanced Permeability and Retention (EPR) Efect: Basis for Drug Targeting to Tumor

  2002cites this paper
• Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.

  2001cites this paper
• Enhanced Vascular Permeability in Solid Tumor Involving Peroxynitrite and Matrix Metalloproteinases

  2001cites this paper
• Bacterial proteinases as targets for the development of second-generation antibiotics.

  2000cites this paper
• Proteinases as Virulence Factors in Bacterial Diseases and as Potential Targets for Therapeutic Intervention with Proteinase Inhibitors

  2000cites this paper
• Kallikrein-kinin in infection and cancer.

  1999cites this paper
• Involvement of Bradykinin Generation in Intravascular Dissemination of Vibrio vulnificus and Prevention of Invasion by a Bradykinin Antagonist

  1998cites this paper
• Isolation of propioxatin A from Actinosynnema sp. SI-23 during a screening for Serratia piscatorum metalloproteinase inhibitors.

  1997cites this paper
• Effect of the molecular weight of water-soluble polymers on accumulation at an inflammatory site following intravenous injection

  1996cites this paper
• Bradykinin Generation Triggered by Pseudomonas Proteases Facilitates Invasion of the Systemic Circulation by Pseudomonas aeruginosa

  1996cites this paper
• Pathogenic mechanisms induced by microbial proteases in microbial infections.

  1996cites this paper
• Recombinant neutral endopeptidase decreases oedema in the skin of burned guinea-pigs.

  1996cites this paper
• Bradykinin and nitric oxide in infectious disease and cancer.

  1996cites this paper
• Species differences in amino acid sequences of Hageman factor and prekallikrein at region around scissile bond in activation.

  1996cites this paper
• Crystal structure of Serratia protease, a zinc-dependent proteinase from Serratia sp. E-15, containing a beta-sheet coil motif at 2.0 A resolution.

  1996cites this paper
• Role of Microbial Proteases in Pathogenesis

  1996cites this paper
• Activation of blood clotting factors by microbial proteinases.

  1994cites this paper
• Therapeutic intervention with chicken egg white ovomacroglobulin and a new quinolone on experimental Pseudomonas keratitis

  1994cites this paper
• Effect of microbial and mite proteases on low and high molecular weight kininogens. Generation of kinin and inactivation of thiol protease inhibitory activity.

  1993cites this paper
• Vascular permeability enhancing activity of Porphyromonas gingivalis protease in guinea pigs.

  1993cites this paper
• Changes of the basal lamina in the rat gingiva receiving incisional wound and bacterial protease application

  1993cites this paper
• Role of bradykinin in microbial infection: enhancement of septicemia by microbial proteases and kinin.

  1993cites this paper
• Bacterial extracellular zinc-containing metalloproteases

  1993cites this paper
• Difference between human and guinea pig Hageman factors in activation by bacterial proteinases: cleavage site shift due to local amino acid substitutions may determine the activation efficiency of serine proteinase zymogens.

  1993cites this paper
• Bacterial extracellular zinc-containing metalloproteases.

  1993cites this paper
• Activation of human plasma prekallikrein by Pseudomonas aeruginosa elastase. II. Kinetic analysis and identification of scissile bond of prekallikrein in the activation.

  1992cites this paper
• Virulence factors in Serratia marcescens: cell-bound hemolysin and aerobactin.

  1992cites this paper
• Primary structure of guinea-pig Hageman factor: sequence around the cleavage site differs from the human molecule.

  1992cites this paper
• Amino acid transport in bacteria.

  1992cites this paper
• Substance P as a potent stimulator of sneeze responses in experimental allergic rhinitis of guinea pigs

  1992cites this paper
• Metalloproteases of Serratia liquefaciens: degradation of purified human serum proteins.

  1991cites this paper
• Vascular Permeability Enhancement by Vibrio mimicus Protease and the Mechanisms of Action

  1991cites this paper
• Pseudomonas aeruginosa alkaline proteinase might share a biological function with plasmin.

  1991cites this paper
• Triggering of the vascular permeability reaction by activation of the Hageman factor-prekallikrein system by house dust mite proteinase.

  1991cites this paper
• Activation of human plasma prekallikrein by Pseudomonas aeruginosa elastase in vitro.

  1991cites this paper
• SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.

  1991cites this paper
• Spreading of Serratia marcescens in experimental keratitis and growth suppression by chicken egg white ovomacroglobulin.

  1991cites this paper
• Activation of human Hageman factor by Pseudomonas aeruginosa elastase in the presence or absence of negatively charged substance in vitro.

  1990cites this paper
• Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease

  1990cites this paper
• Inactivation ofChemotactic Activity ofC5abytheSerratial 56-Kilodalton Protease

  1990cites this paper
• Activation of the plasma kallikrein-kinin system by Candida albicans proteinase

  1990cites this paper
• Pseudomonas elastase acts as a virulence factor in burned hosts by Hageman factor-dependent activation of the host kinin cascade

  1989cites this paper
• Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens

  1989cites this paper
• Cytotoxicity of bacterial proteases in various tumor cells mediated through alpha 2-macroglobulin receptor.

  1989cites this paper
• alpha 2-macroglobulin traps a proteinase in the midregion of its arms. An immunoelectron microscopic study.

  1989cites this paper
• Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases.

  1989cites this paper
• Hageman factor dependent kinin generation system in guinea pig skin: extravascular localization of the components, and prolonged vascular reaction in inhibitor-depleted animal of this system.

  1989cites this paper
• Pathogenic potentials of bacterial proteases.

  1989cites this paper
• Molecular mechanism of complex infection by bacteria and virus analyzed by a model using serratial protease and influenza virus in mice

  1989cites this paper
• Inactivation ofVarious Proteinase Inhibitors andtheComplement SysteminHumanPlasmabythe56-Kilodalton Proteinase fromSerratia marcescens

  1989cites this paper
• Improvement of Pharmacological Properties of Protein-Drugs by Tailoring with Synthetic Polymers

  1988cites this paper
• Cleavage ofImmunoglobulin G (IgG) andIgAaround the HingeRegion byProteases fromSerratia marcescens

  1988cites this paper
• The Hageman factor-dependent system in the vascular permeability reaction.

  1988cites this paper
• Staphylococcus epidermidis の産生するslime の病原性と protease 活性との関連について

  1988cites this paper
• Characterization of 73 kDa thiol protease from Serratia marcescens and its effect on plasma proteins.

  1988cites this paper
• Comparison of four hemolysin-producing organisms (Escherichia coli, Serratia marcescens, Aeromonas hydrophila, and Listeria monocytogenes) for release of inflammatory mediators from various cells

  1988cites this paper
• Interdomain cleavage of plasma fibronectin by zinc-metalloproteinase from Serratia marcescens.

  1988cites this paper
• Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue

  1988cites this paper
• Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens

  1988cites this paper
• Interactions of purified Serratia marcescens metalloproteases with fresh human serum and with purified human serum proteins.

  1987cites this paper
• Antitumor activity of some bacterial proteases: eradication of solid tumors in mice by intratumor injection.

  1987cites this paper
• Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections

  1987cites this paper
• Interstitial-tissue localization of high-molecular-weight kininogen in guinea-pig skin.

  1987cites this paper